President Donald Trump said on Tuesday that the United States would initially place a "small tariff" on pharmaceutical ...

Heart murmurs occurring in nearly one in four adults, but recordings of stethoscope sounds have limited sensitivity in ...

US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...

We will be totally self-sufficient for the supply of medicines to American patients.” AstraZeneca CEO Pascal Soriot on the ...

AstraZeneca’s CEO said the company has proposed U.S. price cuts to some drugs, while Doximity enters competitive AI scribing ...

Today’s Forbes CFO newsletter focuses on Aradhana Sarin’s journey from treating patients to becoming what she calls a ...

The pharmaceutical giant said second-quarter revenue increased to $14.46 billion from $12.94 billion. U.S. revenue was up 13% ...

Trump is pushing drug companies to lower their prices, but experts cast doubt on how effective this endeavor will prove.

The Department of Health and Human Services (HHS) is winding down its mRNA vaccine development activities under the ...

Out-licensing drugs to multinational corporations is a natural step for Chinese biotechs, but the recent rise in deals is ...

In an earnings call on July 29th, in which the company reported a 13% increase in half-year profits, he said about Britain ...

While a substantial portion of pipeline assets are externally sourced, many Big Pharmas are tapping into incubators and ...